J Med Microbiol Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MacKenzie, C. R.
Right arrow Articles by Daubener, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MacKenzie, C. R.
Right arrow Articles by Daubener, W.
Agricola
Right arrow Articles by MacKenzie, C. R.
Right arrow Articles by Daubener, W.

The Journal of Medical Microbiology, Vol 48, Issue 10 935-941, Copyright © 1999 by Society for General Microbiology


JOURNAL ARTICLE

Growth inhibition of multiresistant enterococci by interferon-gamma-activated human uro-epithelial cells

C. R. MacKenzie, C. Hucke, D. Muller, K. Seidel, O. Takikawa and W. Daubener
Institute for Medical Microbiology and Virology, Heinrich-Heine University, Dusseldorf, Germany. colin.mackenzie@uni-duesseldorf.de

Nosocomial infections with enterococci are an increasing problem in modern medical practice due to the development of resistance to a wide range of antibiotics, including the glycopeptides vancomycin and teicoplanin. An increasing number of vancomycin-resistant enterococci (VRE) have been cultured from clinical specimens -- especially from patients undergoing immunosuppressive therapy -- and bacteraemia caused by these VRE, subsequent to colonisation of epithelial surfaces, is a significant cause of mortality in such patients. Recent evidence showed that the induction of indoleamine 2,3 dioxygenase (IDO) by interferon-gamma (IFN-gamma) inhibited growth of group B streptococci by depleting the essential amino acid L-tryptophan. This study describes the IFN-gamma-induced expression of IDO -- shown at a transcriptional level by Northern blot analysis, at translational level by Western blot and also at a functional level by L-tryptophan degradation to L-kynurenine -- in the uro-epithelial cell line RT4. The depletion of L-tryptophan resulted in growth inhibition of enterococci, and this was confirmed by abrogation of the inhibitory effect by re-supplementation with excess L-tryptophan. Multiresistant enterococci, including vancomycin-resistant strains resistant to all commercially available antibiotics, were inhibited by the IFN-gamma-induced expression of IDO and subsequent L-tryptophan degradation. This may be an important mechanism in the local restriction of colonisation of the urinary tract by endogenous enterococci and in inhibiting the spread of the bacteria beyond the epithelial barrier.


This article has been cited by other articles:


Home page
Infect. Immun.Home page
C. Hucke, C. R. MacKenzie, K. D. Z. Adjogble, O. Takikawa, and W. Daubener
Nitric Oxide-Mediated Regulation of Gamma Interferon-Induced Bacteriostasis: Inhibition and Degradation of Human Indoleamine 2,3-Dioxygenase
Infect. Immun., May 1, 2004; 72(5): 2723 - 2730.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
P. Sedlmayr, A. Blaschitz, R. Wintersteiger, M. Semlitsch, A. Hammer, C.R. MacKenzie, W. Walcher, O. Reich, O. Takikawa, and G. Dohr
Localization of indoleamine 2,3-dioxygenase in human female reproductive organs and the placenta
Mol. Hum. Reprod., April 1, 2002; 8(4): 385 - 391.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS
Copyright © 1999 Society for General Microbiology.